A randomized comparison of an immunosuppressive strategy using tacrolimus and cyclosporine in black heart transplant recipients

Transplantation Proceedings

Volumn 33, Issue 1-2, 2001, Pages 1606-1607

  Mehra, M R ^a,b   Uber, P A ^a   Park, M H ^a   Prasad, A K ^a   Scott, R L ^a  

^a OCHSNER MEDICAL CENTER   (United States)

^b BH 326 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HLA ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG METABOLISM; GENETICS; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; NEGRO; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECIPIENT; SURVIVAL RATE;

AFRICAN CONTINENTAL ANCESTRY GROUP; CYCLOSPORINE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFECTION; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TACROLIMUS;

EID: 0035077249     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)02611-7     Document Type: Conference Paper

References (8)

1. Mills RM, Naftel DC, Kirklin JK, et al: J Heart Lung Transplant 16:813, 1997
2. Taylor DO, Barr ML, Radovancevic B, et al: J Heart Lung Transplant 18:336, 1999
3. Kobashigawa J, Miller L, Renlund D, et al: Transplantation 66:507, 1998
4. Jiang H, Kobayashi M: Transplant Proc 31:1978, 1999
5. Jurcevic S, Dunn MJ, Crisp S, et al: Transplantation 65:1197, 1998
6. Hubner GI, Eismann R, Sziegoleit W: Ther Drug Monit 21:536, 1999
7. Chocair PR, Duley JA, Sabbaga E, et al: Q J Med 86:359, 1993
8. Opelz G, Mytilineos J, Scherer S, et al: Transplant Proc 29:3333, 1997